Patients should contact their healthcare provider if they experience: Signs of infection at injection sites , including increasing warmth, redness spreading beyond the immediate injection area, purulent drainage, or fever
Your provider should document your surgical history and monitor digestive changes during the first few weeks of treatment, but many post-cholecystectomy patients use semaglutide successfully
All semaglutide products should never be frozen
February 2, 2026: Gastroparesis is Most Common Injury in Lawsuits Against Ozempic and Other GLP-1 Drugs According to court documents, gastroparesis is the most frequently listed injury in complaints filed as part of the GLP-1 product liability litigation (MDL -3094), which includes Ozempic claims
10.3390/nu15183955 [DOI] [PMC free article] [PubMed] [Google Scholar] Franklin M, Bermudez I, Murck H, Singewald N, Gaburro S (2012) Sub-chronic dietary tryptophan depletionan animal model of depression with improved face and good construct validity
Mina Maleki: Writing review & editing